Shanghai Green Valley Wins China Approval for Alzheimer’s Drug

China’s National Medical Products Administration granted conditional approval to the drug Oligomannate (GV-971), the regulator said in a statement on its website. Shanghai Green Valley Pharmaceuticals ...

Read the original article: shanghai china - BingNews